A detailed history of Meiji Yasuda Asset Management CO Ltd. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Meiji Yasuda Asset Management CO Ltd. holds 12,751 shares of EW stock, worth $953,902. This represents 0.03% of its overall portfolio holdings.

Number of Shares
12,751
Previous 15,341 16.88%
Holding current value
$953,902
Previous $1.42 Million 40.65%
% of portfolio
0.03%
Previous 0.06%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$59.7 - $93.78 $154,623 - $242,890
-2,590 Reduced 16.88%
12,751 $841,000
Q2 2024

Aug 12, 2024

BUY
$84.3 - $94.31 $15,511 - $17,353
184 Added 1.21%
15,341 $1.42 Million
Q1 2024

May 15, 2024

BUY
$72.54 - $95.56 $271,662 - $357,872
3,745 Added 32.82%
15,157 $1.45 Million
Q4 2023

Feb 14, 2024

SELL
$61.71 - $77.76 $45,973 - $57,931
-745 Reduced 6.13%
11,412 $870,000
Q3 2023

Nov 13, 2023

BUY
$69.28 - $93.38 $27,019 - $36,418
390 Added 3.31%
12,157 $842,000
Q2 2023

Aug 14, 2023

BUY
$81.41 - $94.33 $80,514 - $93,292
989 Added 9.18%
11,767 $1.11 Million
Q1 2023

May 09, 2023

BUY
$74.26 - $84.51 $99,137 - $112,820
1,335 Added 14.14%
10,778 $892,000
Q4 2022

Feb 14, 2023

SELL
$68.3 - $87.44 $25,954 - $33,227
-380 Reduced 3.87%
9,443 $705,000
Q3 2022

Nov 14, 2022

SELL
$82.37 - $107.29 $82,370 - $107,290
-1,000 Reduced 9.24%
9,823 $812,000
Q2 2022

Aug 16, 2022

BUY
$86.5 - $128.27 $66,605 - $98,767
770 Added 7.66%
10,823 $1.03 Million
Q1 2022

May 17, 2022

SELL
$101.96 - $128.34 $163,951 - $206,370
-1,608 Reduced 13.79%
10,053 $1.18 Million
Q4 2021

Feb 14, 2022

BUY
$106.37 - $130.68 $110,731 - $136,037
1,041 Added 9.8%
11,661 $1.51 Million
Q3 2021

Nov 12, 2021

BUY
$102.91 - $122.75 $26,756 - $31,915
260 Added 2.51%
10,620 $1.2 Million
Q1 2021

May 14, 2021

BUY
$78.68 - $90.67 $226,598 - $261,129
2,880 Added 38.5%
10,360 $867,000
Q4 2020

Feb 12, 2021

SELL
$71.69 - $91.23 $28,676 - $36,492
-400 Reduced 5.08%
7,480 $682,000
Q3 2020

Nov 12, 2020

SELL
$67.19 - $87.44 $335,278 - $436,325
-4,990 Reduced 38.77%
7,880 $629,000
Q2 2020

Aug 13, 2020

BUY
$57.54 - $76.95 $580,003 - $775,656
10,080 Added 361.29%
12,870 $889,000
Q1 2020

May 14, 2020

SELL
$52.41 - $81.0 $101,151 - $156,330
-1,930 Reduced 40.89%
2,790 $526,000
Q4 2019

Feb 13, 2020

BUY
$71.7 - $82.09 $14,340 - $16,418
200 Added 4.42%
4,720 $1.1 Million
Q2 2019

Aug 13, 2019

SELL
$55.74 - $64.41 $35,952 - $41,544
-645 Reduced 12.49%
4,520 $835,000
Q2 2018

Aug 13, 2018

SELL
$42.45 - $51.3 $63,462 - $76,693
-1,495 Reduced 22.45%
5,165 $752,000
Q3 2017

Nov 08, 2017

BUY
$36.29 - $38.83 $241,691 - $258,607
6,660
6,660 $728,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.3B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Meiji Yasuda Asset Management CO Ltd. Portfolio

Follow Meiji Yasuda Asset Management CO Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meiji Yasuda Asset Management CO Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Meiji Yasuda Asset Management CO Ltd. with notifications on news.